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Abstract
Using the Xenopus oocyte expression system, we have previ-
ously identified an -4-kb fraction ofmRNA from rat liver that
expresses sulfobromophthalein-glutathione (BSP-GSH)-in-
sensitive reduced glutathione (GSH) transport (Fernandez-
Checa, J., J. R. Yi, C. Garcia-Ruiz, Z. Knezic, S. Tahara, and
N. Kaplowitz. 1993. J. Biol. Chem. 268:2324-2328). Starting
with a cDNA library constructed from this fraction, we have
now isolated a single clone that expresses GSH transporter
activity. The cDNA for the rat canalicular GSH transporter
(RcGshT) is 4.05 kb with an open reading frame of 2,505 nu-
cleotides encoding for a polypeptide of835 amino acids (95,785
daltons). No identifiable homologies were found in searching
various databases. An - 96-kD protein is generated in in vitro
translation of cRNA for RcGshT. Northern blot analysis re-
veals a single 4-kb transcript in liver, kidney, intestine, lung,
and brain. The abundance of mRNA for RcGshT in rat liver
increased 3, 6, and 12 h after a single dose of phenobarbital.
Insensitivity to BSP-GSH and induction by phenobarbital,
unique characteristics of canalicular GSH secretion, suggest
that RcGshT encodes for the canalicular GSH transporter. (J.
Clin. Invest. 1994. 93:1841-1845.) Key words: glutathione.
transport* organic anions * phenobarbital . induction
Introduction
The liver plays a key role in interorgan reduced glutathione
(GSH)' homeostasis, releasing GSH at the sinusoidal pole into
plasma and at the canalicular pole into bile (1). Efflux at both
poles appears to be carrier mediated by low affinity systems
that exhibit multispecificity in hepatic uptake and biliary secre-
tion of certain organic anions (1-3). Furthermore, canalicular
GSH secretion is an important determinant of bile acid-inde-
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1. Abbreviations used in this paper: BSP, sulfobromophthalein; GSH,
reduced glutathione; RcGshT, rat canalicular GSH transporter.
pendent bile flow (4). Physiologic differences in the transport
ofGSH at the two poles of the hepatocyte have suggested the
existence of two distinct transport systems, possibly encoded
by distinct genes. The canalicular transporter activity is inhib-
ited by sulfobromophthalein (BSP) but not by BSP-GSH (2,
5), and is induced by phenobarbital (5), whereas the sinusoi-
dal transporter is inhibited by BSP-GSH (2, 3), and is not
induced by phenobarbital (5). Recently, we have identified
two distinct size class mRNAs from rat liver that express GSH
transport in Xenopus laevis oocytes: - 2.5-kb mRNA that en-
codes for a BSP-GSH-inhibitable GSH transporter (putative
sinusoidal) and - 4-kb mRNA that encodes for a GSH trans-
porter insensitive to BSP-GSH (putative canalicular) (6). We
now report for the first time the cloning and molecular charac-
terization ofan hepatic GSH transporter with characteristics of
the canalicular transporter.
Methods
RNA isolation, oocyte preparation, and transport. Isolation of
poly(A)+ RNA from rat liver (male Sprague Dawley rats, 200-250 g),
size fractionation, and microinjection ofmRNA and cRNA into stage
5 and 6 defolliculated X. oocytes were performed as previously de-
scribed (6). GSH uptake and effilux were determined as previously
described using [I35S]GSH and unlabeled GSH (6) 2 or 3 d after injec-
tion ofmRNA, cRNA, or water. For uptake, 10mM extracellular GSH
with or without 5 mM BSP-GSH was used, and for efflux, oocytes were
injected with 66 nl per oocyte containing either 16 nmol GSH±4 nmol
BSP-GSH versus water alone. These are the identical conditions as in
our previous report (6). Verification of the molecular form of the ra-
diolabel transported was performed by HPLC (6). As in our previous
studies (6), no evidence ofbreakdown products of [351 ]GSH was seen
in HPLC of cells or medium in either uptake or efflux experiments.
[35S]GSH was obtained from DuPont-New England Nuclear (Boston,
MA) ( 145 Ci/mmol).
cDNA library construction and clone isolation. The 3.5-4.0-kb
mRNA size fraction that conferred peak stimulation of GSH uptake/
efflux (BSP-GSH insensitive) in Xenopus oocytes was used to con-
struct a directional cDNA library in the expression vector, pcDNA 1
(Invitrogen, San Diego, CA). Briefly, size-fractionated mRNA was
used as a template for cDNA construction using reverse transcriptase
and a synthetic oligo(dT)-Notl primer. The conversion of RNA-
cDNA hybrid into double-stranded cDNA was done by using RNAseH
in combination with DNA polymerase 1 and Escherichia coli DNA
ligase. BstxI adaptors were then added to the double-stranded cDNA at
the 5' end, and the resulting cDNA was subsequently ligated to the
previously BstxI- and NotI-digested plasmid vector, pcDNAl, which
was then electroporated into MC 1060/p3 cells. The cDNA inserts in
this vector are flanked by T7 and SP6 RNA polymerase promoters at
their 5' and 3' ends, respectively, allowing production ofboth sense and
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antisense cRNA transcription. The library consisted of- 5 x 106 colo-
nies.
For screening, a pool of plasmid DNA was prepared from the li-
brary (200 ,g) and aliquots (1 l) were electroporated into E. coli. The
transformants were divided in four groups. Plasmid DNA from each
group of colonies was prepared by an alkali-SDS lysis method using a
Mag DNA purification kit (Promega Biotec, Madison, WI). Plasmid
DNA was linearized with NotI and in vitro transcribed with T7 RNA
polymerase in the presence of the GpppG cap, using a protocol sup-
plied with the Riboprobe transcription system (Promega Biotec). The
complementary RNA (cRNA) from the same pool of colonies was
injected into oocytes. This procedure was repeated four times (I-Ml
aliquots ofthe total plasmid pool) until a pool that induced the uptake
of [35S]GSH 10-fold over background was identified and sequentially
subdivided into four groups ofcolonies twice, each time usingcRNA to
express activity. At that point, 500 colonies remained; an individual
plasmid pool was prepared from each colony (1-2 ,g DNA in 50 ,l
H20 each). 5-id aliquots of each individual pool were mixed into two
groups of pools representing 250 colonies. cRNA prepared from each
was used to express activity in oocytes. From the plasmid DNA of250
colonies shown to contain the rat canalicular GSH transporter
(RcGshT) activity, 5 pools of 50 individual plasmids (5-M1 aliquots)
were mixed and the one expressing GSH transport was identified. 5
pools of 10 individual plasmids from these 50 were then mixed and
screened. The individual 10 plasmids from the positive pool were then
screened and the single positive one identified.
Northern blot analysis ofthe cDNA clone. Poly(A)+ RNA (5 ug)
prepared from various rat tissues was separated on a 1% agarose gel
with 6.7% formaldehyde, blotted onto a nylon membrane by capillary
transfer, then hybridized to a 1.5-kb cDNA derived from a subcloned
insert (BamHI-XbaI fragment) corresponding to nucleotide 1132-
2623 labeled with 32P by random priming (Primer-It II Kit; Stratagene,
La Jolla, CA). Hybridization was at 42°C overnight in 50% form-
amide, 6x SSPE (0.18 M NaCl, 10 mM sodium phosphate, pH 7.7, 1
mM EDTA), 2% SDS containing 100 Mg/ml salmon sperm DNA and
I07 dpm labeled insert. Blots were washed twice for 10 min in 2X SSC,
0.1% SDS at room temperature, twice for 30 min in 0.1 X SSC (0.15 M
NaCl, 0.0 15 M sodium citrate, pH 7.0), 0.5% SDS at 65°C, then twice
for 30 min in 0.1 X SSC at room temperature, and autoradiographed for
3 d onto HyperfilmR (Amersham Corp., Arlington Heights, IL) using
image-intensifying screens.
In vitro translation ofRcGshTcRNA. In vitro translation ofcloned
RcGshT cRNA was performed by using a rabbit reticulocyte system
(Promega Biotec) and [35SImethionine (DuPont-New England Nu-
clear) ( 1200 Ci/mmol) according to the instructions of the manufac-
turer. Translated protein was run in SDS-PAGE and autoradiographed
as above.
Effect of phenobarbital on RcGshT mRNA. Fed male Sprague-
Dawley rats (250 g) were injected with a single dose of phenobarbital
(80 mg/kg in saline i.p.) or equal volume of saline 3, 6, or 12 h before
isolation of total liver RNA. 20 gg of each total RNA was run on
agarose gel electrophoresis, transfered to nylon membrane, and hybrid-
ized with a 32P-labeled RcGshT DNA fragment, as described above.
The same membrane was rehybridized with 32P-labeled rat fl-actin
cDNA (Clontech, Palo Alto, CA). Autoradiography and densitometry
(2222-020 Ultra Scan XL laser densitometer with software 3.0; LKB,
Piscataway, NJ) were used to quantitate relative RNA. Phenobarbital-
induced transcript densities were normalized to saline controls to esti-
mate fold increase.
Sequence analysis of the cDNA. The insert of cloned cDNA was
digested with different restriction enzymes and the resulting fragments
ofcDNA were subcloned into the plasmid vector pGEM-fl I (-) (Pro-
mega Biotec). The nucleotide sequence from each of the subcloned
fragments was determined by dideoxy chain termination using the Se-
quenase DNA sequence kit (U.S. Biochem. Corp., Cleveland, OH).
Both strands ofthe clone were sequenced using SP6 and T7 sequencing
primers. cDNA-specific oligonucleotide primers were also used to
complete the sequencing analysis. Comparison of RcGshT amino acid
and nucleotide sequences were performed with GCG software (Univer-
sity of Wisconsin Genetics Computer Group Program Package) to
search GenBank, EMBL, Swiss Prot, and PROSITE data bases.
Results and Discussion
The previously identified 3.5-4-kb mRNA size fraction from
rat liver that expressed BSP-GSH-insensitive transport ofGSH
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Figure 1. GSH transport in X. Iaevis oocytes. Qocytes were injected
with RcGshT cRNA (0.3 ng), poly(A)+ RNA (30 ng), or water (33
nl). 2 d later, GSH efflux (top) or uptake (bottom) were determined.
For efflux, oocytes were loaded with [35S]GSH ( 16 nmol) with or
without BSP-GSH (4 nmol), and efflux was immediately determined.
For uptake, oocytes were exposed to medium containing [35S ]GSH
(10 mM) with or without BSP-GSH (5 mM). Results of experiments
with three different oocyte preparations are shown as mean±SD, with
open bars representing the absence and hatched bars the presence of
BSP-GSH.
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(6) was used to construct a cDNA library. After screening mul-
tiple subdivisions, a single clone (RcGshT) was isolated that
expressed GSH efflux and uptake in oocytes (Fig. 1). When
corrected for equivalent amount ofRNA injected into oocytes,
the cRNA ofthe individual clone exhibited > 100-fold enrich-
ment in transport activity compared with total rat liver
poly( A) + RNA whether or not the values for water controls are
first subtracted. As expected, BSP-GSH did not cis-inhibit up-
take or efflux ofGSH after expression of RcGshT, but partially
inhibited after expression of total poly(A)+ RNA due to the
coexpression of the putative sinusoidal GSH transporter.
The DNA sequence and deduced amino acid sequence of
RcGshT are shown in Fig. 2. The cDNA insert consists of4,050
nucleotides with an open reading frame of 2,505 nucleotides,
predicting a polypeptide of 835 amino acids with a molecular
mass of 95,785 daltons. The start codon was identified accord-
ing to the model of Kozak (7). Kyte-Doolittle analysis (8) was
consistent with an integral membrane protein with 1O possible
membrane-spanning domains, 4 of which are strongly hydro-
phobic (amino acids 102-120, 126-148, 168-187, 386-404),
and an additional 6 that are of appropriate length but with
weaker hydrophobicity (193-211, 258-278, 324-346, 475-
493, 550-568,683-704). There is no cleavable signal sequence
indicating that the NH2 terminus is likely to be cytoplasmic.
Five possible N-linked glycosylation sites (amino acids 10, 55,
466, 573, and 638) are present as well as multiple potential
phosphorylation sites (protein kinase A [PKA] site at amino
acid 282; tyrosine kinase site at 679; PKC sites at 198, 255, 315,
326,429,498, 536, 592,644,758, and 791; and casein kinase II
sites at 24, 57, 156, 227, 411, 684, and 787). No significant
amino acid or nucleotide sequence homology (defined as
> 10%) could be identified in searching current data bases of
nucleotide and amino acid sequences.
The prediction that RcGshT encodes for an integral mem-
brane protein with multiple membrane-spanning domains sug-
gests that this is the transporter polypeptide. However, a role
for this gene product in activating a latent endogenous oocyte,
as well as rat liver, transporter is impossible to exclude entirely
at this time. This is a general reservation that can be made with
nearly all the membrane transporters cloned to date.
In vitro translation using a rabbit reticulocyte system re-
vealed a polypeptide of - 96 kD on SDS-PAGE (Fig. 3), in
close agreement with the predicted molecular mass calculated
from the open reading frame. A single hybridizable transcript
of - 4.0 kb was identified on Northern blot analysis ofrat liver
(Fig. 4). Analysis of other organs revealed a similar single hy-
bridization signal in brain, kidney, intestine, and lung, and no
signal in heart (Fig. 4). The localization in the kidney suggests
that this gene may be responsible for the known apical secre-
tion of tubular epithelial GSH (9), which is key element ofthe
intrarenal gamma-glutamyl cycle (9). Little is known about
apical GSH transport by intestinal or lung epithelial cells; how-
ever, in the case of lung, it is of interest that alveolar fluid GSH
achieves near millimolar concentrations (1O). The high levels
of transcripts in the brain is somewhat surprising. Although a
blood-brain barrier transport of GSH has been suggested (11,
12), it has also been reported that astrocytes efflux GSH (13).
Further work will be required to identify the cell type in the
brain in which this transporter mRNA is expressed.
The identification ofRcGshT as encoding for the canalicu-
lar transporter is suggested on the basis of its insensitivity to
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CCCATACTCCCGCTAAAAACTCATAATCCCAAAAAGATAAATATAAAAATATCACTGAG
TCAATCAATAATAATTTGGCATCACGAGCACACATCACAGAGGAATATTATGAGCCAQ GA
M S T E
AACAATTGAAATATTCAATAAGTGATGAATGGGCAAATCAACTAAAACACGCATTATC
T I E I F N N S D E W A N Q L K H A L S
GAAAGGAGAAAATCTGGCATTCTACATGGTTTAACTCCTGATATCCTTGATAGAATATA
K G E N L A L L H G L T P D I L D R I Y
TGCATATGCATTCGACTACCATGaAAAGGGTAATATAAcGGACGCAGAAAmTATTATAA
A Y A F D Y H E K G N I T D A E I r Y K
ATTCTTGTGCATATGCGTTCGAAAATCATGAGTATCTAAAAGATTTTGGCATCAGTAT
F L C I Y A F E N H E Y L K D F G I S M
GTTCAGCCCACAAAGAAATATCAACAAGCATATTGACGCTTTACAAACTAAGTTACAATT
F S P Q R N I N K H I D A L Q T K L Q L
ACTTCCCGGTATGATGACTATTCAGTTATTTATCGTATGGGTCAATGTCAGATTGGGGCT
L P G M M T I Q L F I V W V N V R L G L
AAAAATATCGATAACGCAAT C TCTATCAATTGTGAGATGAT
K I S I T Q C N V S I T L L T I V R M I
AGTGTTAAGAGTAAAGCGCAGGCATATATTGAACTCTCAA&CGATAATTCAGAAGATAA
V L R V K R R H I L N S L N D N S E D N
TCGGCTAAGCATTACAATCATTTGGTTAAATTTGCTGGTATAGTGCAGTTAACCACTAT
R L S I T I I W L N L L V I V Q L T T I
AACCAGCACCTCTTATGTTTTCTTAAATCAGCATCT A _AACAGTTAAGACTACTACA
T S T S Y V F L N Q H L K T V K S I L Q
_ATCATTATTTTTCAATGCGTTAGAGAACAATCTACTTTATCACCTTGAATAAGGCTTA
I I I F Q C V R E Q S T L S P L NK A Y
TTCAGATTCAATCACTGAAACATCACTGAATTCTAAGATACCACCAAGAAGATTTGCCCT
S D S I T E T S L N S K I P P R R F A L
TATTGGAGATTCCCTGGAAGCGGTTGATTTGACGACCAGAAACGCGAATGACGCCATAAT
I G D S L E A V D L T T R N A N D A I I
TTTCCTTTTTGCGTGCGAGGGATTGCAAGGCCCCGTTTTTTTCAAGAGGGGTTCCCTGGG
F L F A C E G L Q G P V F F K R G S L G
GGGGGCTAAGAAAGATAAAATTCTCATATCATTTTCTTGGGGGATTCCCGCTCGGGGGAA
G A K K D K I L I S F S W G I P A R G K
GATGGACTTCCTAAGATACATTAGTGAACCCACCCAAAGATATGCCATATGTAATTTCCT
N D F L R Y I S E P T Q R Y A I C N F L
GAACACCATAAAATTTGAAATACCCATAATTTCCTATTGCCTGAAAGGGGGGATCCAAGC
N T I K F E I P I I S Y C L K G G I Q A
CCCCAATTTTTTCATA0GGGGGTTACCC0 GTGGACAAAAGAAA0TAAAATTCTCATATC
P N F F I G G Y P G G Q K K D K I L I S
ATTTTCTTGGGGGATTCCCGCTCG(4ATTC [ A C-U04 AATGAGCAAGTATAT
F S W G I P A R G I L T Q G N E Q V Y I
TCCACAGAAAGAGTT AGGTGTA0 r AGTATTACTTUA(TCCGCYGGTCATGTTGTACT
P Q K E L G V L I V L L E S A G H V V L
GAAAGATATGATCATCGAATCAGTATGGGATAC_ A _ATTAT TGACGAGTCCCCGAC
K D M I I E S V W E N I I V S D E S P T
AAAAAGTATCTATTCTTGCGCCGCA Ac0CT 1caTAGA
K S I Y S L R R I F G K I G Y Y R C I E
AACAATCTACCGGAA AG0TTATCGTTTCAGCGGGCAGGTTCCAAAACTAAAATTAATGA
T I Y R K G Y R F S G Q V P K T K I N E
AGATAATACTTCAGACTATTCCATAGCTATATTCC ACTA 5TTCTA TACACT
D N T S D Y S I A I F P F T T S L N T L
GGATCCATTAATACTTAATCAGGAATTAGTCC ATCATTTCA ATAAAAAATCGATGG
D P L I L N Q E L V Q I I S N K K I D G
TCTCTATACCTATCCGATGGCTGCGACAAATTT0TGTAAT0CTCAAAATCTCAAAATTC
L Y T Y P N A A T N F C N D H I S Q N S
ATTCTTGAGCAGATTCAAGCCAGATTATTTCGTTACAGGAAGAATIAACCAGAATAATGC
F L S R F K P D Y F V T G R I N Q N N A
IO AGTGAACACTTTATACATTGAGTTGATCGACGCTAAAAACCTTTTCCTCATCGCCAGTAA
5 V N T L Y I E L I D AK N L F L I A S N
)O TCATCTCCCTGTTGAT TT T TATCCTTCA
i5 H L P V D E L H N T S Q F I I D N I L Q
iO AACGGTACATAAACCAGAACGATCTGTAAGATTAGCTAAGCAGGACCAAGGATATAAGAA
15 T V H K P E R S V R L A K Q D Q G Y K N
LO TCATTATTTATCAGATGAAATGTTAGCCGGAAAGAAAGAACTTTACGACTTCACCCCTGA
)5 H Y L S D E M L A G K K E L Y D F T P E
1O AAGCATTTCAAGGGCCATCGATT TCAAGAC
!5 S I S R A I D I F D R F K N K T D I K T
O GCTAAAAACAGAATGTTATTCCGTTCTAGCGGAATGCCATATGTCTTGGCACTTCATGG
L5 L K T E C Y S V L A E C H N S L A L H G
O AAAAAGTGAACTTGCTGCTCAAAGCATTAGAGCTTITAGATTATGTATCAGACATAAC
i5 K S E L A A Q K A L E L L D Y V S D I T
jO CACTGTCGATGGAAAAATTTTAGCTATTATGGG&CTG&TAACTGGTCTGTCTGGACAAGC
15 T V D G K I L A I N G L I T G L S G Q A
LO AAAAGTATCTCATATCTTATTTACACTACGCCCCGGCTTG&TAATAGCCCT
)5 K V S H I L F E Q A K I R P G L I I A L
PO CTCCTCTCCTACCAAGGGGGCACTAAGCCCCCCTTTCATTGTTGGAGAAAATGAAGAGCC
!5 S S P T K G A L S P P F I V G E N E E P
IO AAGGATTTGTATAGCCAAATCGCTACAACGCGAACCCAGAAGCCGAAAAGCAGGTTGTGA
15 R I C I A K S L Q R E P R S R K A G C D
O TAGAAGATGTGTAGATATGTATGTGCCTAACCCGCCCAAAAACAACATTAAACTCTACTA
;5 R R C V D M Y V P N P P K N N I K L Y Y
O TAAAGAAACTGAGAGTGAAAGCCATCGAGTTATAATTGACAACATTTTGAATTAAAGCA
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Figure 2. Nucleotide and deduced amino acid sequence of RcGshT.
The first nucleotide and amino acid residue of the start site are desig-
nated as position 1 and the termination codon follows the last amino
acid residue. Polyadenylation signal sequence is underlined. These
sequence data have been submitted to EMBL/GenBank under ac-
cession number U06845.
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Figure 3. In vitro translation of
RcGshT cRNA in the rabbit reticulo-
cyte lysate system. Shown is an auto-
radiograph of the reaction mixture
after SDS-polyacrylamide (8%) gel
electrophoresis. The locations of pro-
tein standards are shown at the right
(kD).1 2
BSP-GSH. However, to add further support to the identity of
RcGshT as the canalicular GSH transporter, we examined the
effect of phenobarbital. Phenobarbital treatment in vivo is
known to induce GSH secretion into bile ( 14) and increase the
Vm. forGSH transport in canalicular-enriched membrane vesi-
cles (5) without affecting sinusoidal GSH efflux in the intact
kb
- 9.49
- 7.46
- 4.40
- 2.37
* _ * _
~~~~~-Actin
0 3 6 12 24 Time (h)
Figure 5. Time course of changes in RcGshT mRNA in rat liver after
phenobarbital treatment. Rats were given phenobarbital (80 mg/kg
i.p.) and killed at 0, 3, 6, 12, and 24 h. Total RNA (20 ,gg) from each
liver was loaded per lane, subjected to electrophoresis, and blotted
as described in Methods. The blots were hybridized with 32P-RcGshT
1.5-kb cDNA fragment and rehybridized with the 32P-actin probe.
liver or GSH transport in sinusoidal-enriched membrane vesi-
cles (5, 14). Indeed, an increase in mRNA was observed at 3, 6,
and 12 h (peak, 6 h) after a single dose of phenobarbital that
subsequently declined to baseline at 24 h; the peak increase was
at 6 h (Fig. 5). An eight- to ninefold increase was found 6 h
after phenobarbital compared with saline treatment deter-
mined in two pairs of rats. The mechanism for this effect of
phenobarbital and the level of regulation (transcription vs.
mRNA stabilization) remain to be determined.
In summary, this is the first report of successful cDNA
cloning of a GSH transporter. Using the Xenopus oocyte ex-
pression system, we have isolated a 4.05-kb cDNA (RcGshT)
from a rat liver library encoding for a polypeptide of835 amino
acids that mediates GSH transport. Insensitivity to BSP-GSH
and induction by phenobarbital provide strong support for its
identification as the canalicular GSH transporter. Immunohis-
tochemistry using polyclonal antibodies to synthetic peptides is
planned to identify the precise cellular and membrane domain
localization ofRcGshT gene product in liver and other organs.
The lack of sequence homology with known transporters indi-
cates that it represents a new family of transporter polypep-
tides. Its wide organ distribution suggests that it plays a role in
GSH turnover (efflux) in many cell types.
- 1.35
Acknowledaments
- 0.24
1 2 3 4 5 6 7
Figure 4. Northern blot analysis of rat tissue distribution of RcGshT
mRNA. 5 ,ug poly(A)+ RNA isolated from rat brain (lane 1), male
liver (lane 2), heart (lane 3), kidney (lane 4), lung (lane 5), small
intestine (lane 6), and female liver (lane 7) were subjected to elec-
trophoresis on 6.7% formaldehyde/ 1% agarose gel, blotted onto a ny-
lon membrane, and hybridized with 32P-labeled 1.5-kb insert of a
subclone of RcGshT corresponding to nucleotides 1132-2623. Blots
were subsequently washed under high stringency (see Methods). Au-
toradiograph was obtained after a 3-d exposure. The scale at the right
indicates position of standard markers (kb).
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